Mangoceuticals Announces TV Air Dates for Interview

Mangoceuticals Announces TV Air Dates for Interview

Dallas, Texas, Oct. 13, 2023 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), an organization targeted on creating, advertising and promoting a wide range of males’s well being and wellness merchandise by way of a safe telemedicine platform, together with its uniquely formulated erectile dysfunction (ED) drug branded “Mango,” is happy to announce that the Company’s CEO, Jacob Cohen, will be a part of Anna Berry on FMW Media’s “New To The Street” enterprise TV present that includes an in-depth interview this weekend. The interview was filmed on the Nasdaq MarketWeb site Studio and can air on Fox Business Network and Bloomberg TV (as a sponsored program) as follows: Saturday, October 14, at 6:30 p.m. ET on Bloomberg TVSunday, October 15, at 3:30 p.m. ET on Fox Business Anna Berry, the host of New to The Street, sits down with Mr. Cohen to debate the Mangoceuticals imaginative and prescient, together with how the Company differentiates itself inside its market and the dynamic methods it’s pursuing to drive progress and shareholder worth as a disruptive participant within the quickly rising males’s well being business. In the interview, Mr. Cohen begins by laying out the Company’s potent technique for differentiating itself as a brand new breed of males’s well being product supplier. According to Cohen, it begins with the concept of an “Erectile Function” tablet as an alternative of an “Erectile Dysfunction” tablet. Through that concept, Cohen believes the Company is positioning itself to faucet into the comparatively untapped youthful demographic, which is mirrored by MangoRx’s dynamic advertising technique. To drive broad demographic consciousness, the Company is tapping into rising podcast and influencer manufacturers with robust traction within the males’s under-40 market whereas additionally sustaining model progress within the above-40 demo. In phrases of chemical differentiation, Cohen describes the MangoRx distinction, noting that many firms promoting direct-to-consumer telemedicine and on-line pharmacy merchandise have primarily targeted on generic merchandise comparable to generic Viagra and generic Cialis (also referred to as sildenafil and tadalafil). “But we determined to take it a step additional. We have give you our proprietary formulation in a compound that has three elements.” Cohen explains that the primary ingredient is both sildenafil or tadalafil. But, setting MangoRx aside from its competitors, that ingredient is paired with oxytocin, “also referred to as the love hormone or what we name the cuddle chemical,” and a 3rd one, L-Arginine, which is an amino acid to advertise vasodilation. “And we not solely compound it in a pill, nevertheless it’s truly an oral dissolvable pill,” which implies you set it in your mouth, and it dissolves underneath the tongue and goes into the bloodstream sooner, permitting it to kick in sooner. “So, our tagline is prepared set mango!” Cohen goes on to debate the Company’s philosophy of cultivating “investor shoppers”—people who find themselves stakeholders each by way of funding positions within the Company in addition to shoppers of MangoRx merchandise, which units a better bar and conveys the dedication the Company has towards driving worth for its shareholders and its clients. The interview concludes with an exploration of the Company’s progressive advertising methods, together with its merchandise, it’s “Make American Hard Again” marketing campaign, its companions like Adam22 and Barstool Sports, and the Company’s robust concentrate on driving accelerating topline progress into yr finish. FMW Media’s “New To The Street” TV model is among the longest-running U.S and International sponsored and Syndicated Nielsen Rated applications operating as we speak. Through its community of syndication, FMW programming reaches an estimated 540 million properties throughout US and worldwide markets. About Mango Created utilizing a particular formulation that includes both the identical energetic ingredient as in Cialis™ (Tadalafil) or Viagra™ (Sildenafil), every a part of the Mango formulation performs a important position in serving to males obtain optimum efficiency. We imagine the important thing to our success lies in our distinctive mix of elements, that are utilized in U.S. Food and Drug Administration (“FDA”) accepted medicine. Mango comprises a mixture of both Sildenafil or Tadalafil together with Oxytocin and L-Arginine which were historically used to deal with sexual dysfunction. Mango is a prescription remedy that should be accepted by a doctor. After a person has accomplished an internet tele-health go to, our community of medical suppliers will assessment and approve a prescription if medically applicable. Mango is a quickly dissolved pill (RDT) that’s absorbed orally. For greatest outcomes, we advise taking Mango a minimum of quarter-hour earlier than partaking in sexual exercise. Sildenafil and Tadalafil, one of many primary elements in Mango, usually have results that last as long as 4 and 36 hours, respectively. About Mangoceuticals Mangoceuticals, Inc. is an organization targeted on creating, advertising, and promoting a wide range of males’s well being and wellness services and products by way of a safe telemedicine platform. To date, the Company has recognized males’s wellness telemedicine companies and merchandise as a rising sector and particularly associated to the world of erectile dysfunction (ED). The Company has developed a brand new model of ED product underneath the model identify “Mango” (suppose: “Man, Go!”). To take part within the Mango Revenue affiliate internet marketing program, please go to: https://mangorevenue.com. For extra info, please go to www.MangoRx.com. Cautionary Note Regarding Forward-Looking Statements Certain statements made on this press launch include forward-looking info inside the which means of relevant securities legal guidelines, together with inside the which means of the Private Securities Litigation Reform Act of 1995 (“forward-looking statements”). These forward-looking statements symbolize the Company’s present expectations or beliefs regarding future occasions and might typically be recognized utilizing statements that embody phrases comparable to “estimate,” “expects,” “mission,” “imagine,” “anticipate,” “intend,” “plan,” “foresee,” “forecast,” “possible,” “will,” “goal” or related phrases or phrases. These forward-looking statements are topic to dangers, uncertainties and different components, a lot of that are outdoors of the Company’s management which may trigger precise outcomes to vary materially from the outcomes expressed or implied within the forward-looking statements, together with, however not restricted to; our potential to acquire extra funding and generate revenues to assist our operations; dangers related to our ED product which haven’t been, and won’t be, accepted by the U.S. Food and Drug Administration (“FDA”) and haven’t had the good thing about the FDA’s medical trial protocol which seeks to stop the potential of severe affected person damage and loss of life; dangers that the FDA could decide that the compounding of our deliberate merchandise doesn’t fall inside the exemption from the Federal Food, Drug, and Cosmetic Act (“FFDCA Act”) supplied by Section 503A; dangers related to associated celebration relationships and agreements; the impact of knowledge safety breaches, malicious code and/or hackers; competitors and our potential to create a widely known model identify; adjustments in client tastes and preferences; materials adjustments and/or terminations of {our relationships} with key events; vital product returns from clients, product legal responsibility, remembers and litigation related to tainted merchandise or merchandise discovered to trigger well being points; our potential to innovate, broaden our choices and compete in opposition to rivals which can have larger assets; our vital reliance on associated celebration transactions; the projected dimension of the potential market for our applied sciences and merchandise; dangers associated to the truth that our Chairman and Chief Executive Officer, Jacob D. Cohen and President, Jonathan Arango, mixed have majority voting management over the Company; dangers associated to the numerous variety of shares within the public float, our share quantity, the impact of gross sales of a big variety of shares within the market, and the truth that nearly all of our shareholders paid much less for their shares than the general public providing value of our widespread inventory in our latest preliminary public providing; the truth that we now have a big variety of excellent warrants to buy shares of widespread inventory at $1.00 per share, the resale of which underlying shares have been registered underneath the Securities Act of 1933, as amended; our potential to construct and preserve our model; cybersecurity, info programs and fraud dangers and issues with our web sites; adjustments in, and our compliance with, guidelines and rules affecting our operations, gross sales, advertising and/or our merchandise; delivery, manufacturing or manufacturing delays; rules we’re required to adjust to in reference to our operations, manufacturing, labeling and delivery; our dependency on third-parties to prescribe and compound our ED product; our potential to determine or preserve relations and/or relationships with third-parties; potential security dangers related to our Mango ED product, together with using elements, mixture of such elements and the dosages thereof; the consequences of excessive inflation, growing rates of interest and financial downturns, together with potential recessions, in addition to macroeconomic, geopolitical, well being and business tendencies, pandemics, acts of battle (together with the continued Ukraine/Russian battle) and different large-scale crises; our potential to guard mental property rights; our potential to draw and retain key personnel to handle our enterprise successfully; our potential to take care of the itemizing of our widespread inventory on the Nasdaq Capital Market; overhang which can scale back the worth of our widespread inventory; volatility within the buying and selling value of our widespread inventory; and common client sentiment and financial circumstances which will have an effect on ranges of discretionary buyer purchases of the Company’s merchandise, together with potential recessions and world financial slowdowns. Although we imagine that our plans, intentions and expectations mirrored in or advised by the forward-looking statements we make on this launch are cheap, we offer no assurance that these plans, intentions or expectations might be achieved. Consequently, you shouldn’t take into account any such checklist to be a whole set of all potential dangers and uncertainties. More info on potential components that might have an effect on the Company’s monetary outcomes is included once in a while within the “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s filings with the SEC, together with the Company’s Quarterly Report on Form 10-Q for the Quarter ended June 30, 2023. These filings can be found at www.sec.gov and at our web site at https://www.mangoceuticals.com/sec-filings. All subsequent written and oral forward-looking statements attributable to the Company or any individual performing on behalf of the Company are expressly certified of their entirety by the cautionary statements referenced above. Other unknown or unpredictable components additionally may have materials opposed results on the Company’s future outcomes. The forward-looking statements included on this press launch are made solely as of the date hereof. The Company can not assure future outcomes, ranges of exercise, efficiency or achievements. Accordingly, you shouldn’t place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to replace these statements after the date of this launch, besides as required by legislation, and takes no obligation to replace or right info ready by third events that aren’t paid for by the Company. If we replace a number of forward-looking statements, no inference ought to be drawn that we are going to make extra updates with respect to these or different forward-looking statements. Follow Mangoceuticals and MangoRx on social media: https://www.instagram.com/mango.rxhttps://twitter.com/Mangoceuticals https://www.fb.com/MangoRxOfficial Or simply click on right here to see why Orange is the brand new Blue: https://www.mangorx.com FOR PUBLIC RELATIONS Lucky Break Public Relations Sahra Simpson [email protected] (323) 602-0091 ext. 704 FOR INVESTOR RELATIONS Mangoceuticals Investor Relations Email: [email protected] MEDIA CONTACT PHOENIX MGMT Marketing & Consulting [email protected] SOURCE: Mangoceuticals Inc.


https://www.globenewswire.com/news-release/2023/10/13/2760006/0/en/Mangoceuticals-Announces-TV-Air-Dates-for-Interview-Featuring-CEO-Jacob-Cohen-on-Bloomberg-TV-and-Fox-Business.html

You May Also Like

About the Author: Amanda